We also find that glimepiride and tolbutamide, two T2D drugs that lower blood glucose by increasing the secretion of insulin, are proximal to cardiac arrhythmia (zc=−3.6 and zc =−2.3, respectively). The gene discussed is INS; the disease is cardiac arrhythmia.